{"id":115812,"date":"2023-12-19T13:04:26","date_gmt":"2023-12-19T07:34:26","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=115812"},"modified":"2023-12-19T13:06:48","modified_gmt":"2023-12-19T07:36:48","slug":"microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/","title":{"rendered":"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-483765252\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>On Tuesday, the shares of India&#8217;s largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3464144765\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>At 12:20 p.m., <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/VENUSREM\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Venus Remedies Ltd<\/a><\/strong> shares were trading at Rs 393.10 per share, up 2.45 percent on the National Stock Exchange from the previous close price. The company has a market capitalization of Rs 401 crore.\u00a0<\/p><p>Venus Remedies Limited has successfully received three new Marketing Authorizations for Enoxaparin, a critical anticoagulant medication. The approved formulations include Enoxaparin 80mg\/0.8ml, 60mg\/0.6ml, and 20mg\/0.2ml.&nbsp;<\/p><p>The approvals have been granted by the regulatory authorities in Bahrain, strategically to expand companies in the Asia (Middle East) region. The company said in its exchange filing.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1989154722\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Enoxaparin injection is used to prevent deep venous thrombosis, Enoxaparin is used to prevent blood clots in the leg in patients who are on bedrest or who are having hip replacement, knee replacement, or stomach surgery.&nbsp;<\/p><p>In the last six months, the stock has gained 110 percent in a year. A shareholder investment of Rs 1 lakh in the company would be worth Rs 2.10 lakhs in a year.&nbsp;<\/p><p>The company\u2019s revenue has jumped by 20 percent yearly, from Rs 139 crore in FY Q2FY23 to Rs 167 crore in Q2FY24. In the same timeframe, Net profit has increased by 86 percent from Rs 5.33 crore to Rs 9.94 crore.&nbsp;<\/p><p>The company has three manufacturing facilities, 800+ market authorizations, 100+ global patents, and a 90+ product basket in its portfolio.<\/p><p>In FY23, the company signed a contract with a renowned biopharma company for Meropenem 500mg (injection) and Meropenem 1gm (injection) taking the company\u2019s total contract manufacturing partnerships to 15+ companies.&nbsp;<\/p><p>In the recent financial year, the company reported a return on equity of 5.77 percent and a return on capital employed at 7.37 percent.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-1847072451\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the business of pharmaceutical product manufacturing.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Omkar Chitnis<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-3031060163\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>On Tuesday, the shares of India&#8217;s largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.&nbsp; At 12:20 p.m., Venus Remedies Ltd shares were trading at Rs 393.10 per share, up 2.45 percent on the National Stock [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":24849,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[948,936,9806,15251,9805],"class_list":["post-115812","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-stock-market","tag-stock-market-news","tag-venus-remedies-latest-news","tag-venus-remedies-latest-orders","tag-venus-remedies-share-price"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"On Tuesday, the shares of India&#039;s largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East\" \/>\n<meta property=\"og:description\" content=\"On Tuesday, the shares of India&#039;s largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-19T07:34:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-19T07:36:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/\",\"url\":\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/\",\"name\":\"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg\",\"datePublished\":\"2023-12-19T07:34:26+00:00\",\"dateModified\":\"2023-12-19T07:36:48+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"On Tuesday, the shares of India's largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East - Trade Brains Features","description":"On Tuesday, the shares of India's largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/","og_locale":"en_US","og_type":"article","og_title":"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East","og_description":"On Tuesday, the shares of India's largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-12-19T07:34:26+00:00","article_modified_time":"2023-12-19T07:36:48+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/","url":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/","name":"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg","datePublished":"2023-12-19T07:34:26+00:00","dateModified":"2023-12-19T07:36:48+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"On Tuesday, the shares of India's largest antibiotics drug maker rose up to 4.5 percent to Rs 401.30 per share after the company received approval to expand its business in the Middle East region.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Markets-5-Cover-Image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/microcap-stock-jumps-up-to-4-5-after-it-receives-approval-to-expand-in-middle-east-region\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Microcap stock jumps up to 4.5% after it receives approval to expand in Middle East"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/115812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=115812"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/115812\/revisions"}],"predecessor-version":[{"id":115814,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/115812\/revisions\/115814"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/24849"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=115812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=115812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=115812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}